On the other hand, it has been shown that the activation of hsa-miR-494-3p exhibits a strong ability to reduce cancer stemness in head and neck squamous cell carcinomas by targeting Bmi1 and ADAM10, which correlates with longer survival time (Chang et al., 2015). This evidence concerns the gene BMI1 and head and neck squamous cell carcinoma.